Activation and Antagonism of the OAS–RNase L Pathway
The oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiti...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/50/1/14 |
id |
doaj-872da033e61548679b09590c8a8ce53d |
---|---|
record_format |
Article |
spelling |
doaj-872da033e61548679b09590c8a8ce53d2020-11-25T02:49:58ZengMDPI AGProceedings2504-39002020-06-0150141410.3390/proceedings2020050014Activation and Antagonism of the OAS–RNase L PathwaySusan R. Weiss0Department of Microbiology, Perelman School of Medicine. University of Pennsylvania, Philadelphia, PA 19104, USAThe oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiting protein production, virus replication and spread, leading to apoptotic cell death. Endogenous host dsRNA, which accumulates in the absence of adenosine deaminase acting on RNA (ADAR)1, can also activate RNase L and lead to apoptotic cell death. RNase L activation and antiviral activity during infections with several types of viruses in human and bat cells is dependent on OAS3 but independent of virus-induced interferon (IFN) and, thus, RNase L can be activated even in the presence of IFN antagonists. Differently from other human viruses examined, Zika virus is resistant to the antiviral activity of RNase L and instead utilizes RNase L to enhance its replication factories to produce more infectious virus. Some betacoronaviruses antagonize RNase L activation by expressing 2′,5′-phosphodiesterases (PDEs) that cleave 2-5A and thereby antagonize activation of RNase L. The best characterized of these PDEs is the murine coronavirus (MHV) NS2 accessory protein. Enzymatically active NS2 is required for replication in myeloid cells and in the liver. Interestingly, while wild type mice clear MHV from the liver by 7–10 days post-infection, RNase L knockout mice fail to effectively clear MHV, probably due to diminished apoptotic death of infected cells. We suggest that RNase L antiviral activity stems from direct cleavage of viral genomes and cessation of protein synthesis as well as through promoting death of infected cells, limiting the spread of virus. Importantly, OASs are pattern recognition receptors and the OAS–RNase L pathway is a primary innate response pathway to viruses, capable of early response, coming into play before IFN is induced or when the virus shuts down IFN signaling.https://www.mdpi.com/2504-3900/50/1/14murine coronavirusoligoadenylate-ribonuclease Linterferon antagonistphosphodiesteraseOAS3ADAR1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Susan R. Weiss |
spellingShingle |
Susan R. Weiss Activation and Antagonism of the OAS–RNase L Pathway Proceedings murine coronavirus oligoadenylate-ribonuclease L interferon antagonist phosphodiesterase OAS3 ADAR1 |
author_facet |
Susan R. Weiss |
author_sort |
Susan R. Weiss |
title |
Activation and Antagonism of the OAS–RNase L Pathway |
title_short |
Activation and Antagonism of the OAS–RNase L Pathway |
title_full |
Activation and Antagonism of the OAS–RNase L Pathway |
title_fullStr |
Activation and Antagonism of the OAS–RNase L Pathway |
title_full_unstemmed |
Activation and Antagonism of the OAS–RNase L Pathway |
title_sort |
activation and antagonism of the oas–rnase l pathway |
publisher |
MDPI AG |
series |
Proceedings |
issn |
2504-3900 |
publishDate |
2020-06-01 |
description |
The oligoadenylate synthetase–ribonuclease L (OAS–RNase L) system is a potent antiviral pathway that severely limits the pathogenesis of many viruses. Upon sensing dsRNA, OASs produce 2′,5′-oligoadenylates (2-5A) that activate RNase L to cleave both host and viral single-stranded RNA, thereby limiting protein production, virus replication and spread, leading to apoptotic cell death. Endogenous host dsRNA, which accumulates in the absence of adenosine deaminase acting on RNA (ADAR)1, can also activate RNase L and lead to apoptotic cell death. RNase L activation and antiviral activity during infections with several types of viruses in human and bat cells is dependent on OAS3 but independent of virus-induced interferon (IFN) and, thus, RNase L can be activated even in the presence of IFN antagonists. Differently from other human viruses examined, Zika virus is resistant to the antiviral activity of RNase L and instead utilizes RNase L to enhance its replication factories to produce more infectious virus. Some betacoronaviruses antagonize RNase L activation by expressing 2′,5′-phosphodiesterases (PDEs) that cleave 2-5A and thereby antagonize activation of RNase L. The best characterized of these PDEs is the murine coronavirus (MHV) NS2 accessory protein. Enzymatically active NS2 is required for replication in myeloid cells and in the liver. Interestingly, while wild type mice clear MHV from the liver by 7–10 days post-infection, RNase L knockout mice fail to effectively clear MHV, probably due to diminished apoptotic death of infected cells. We suggest that RNase L antiviral activity stems from direct cleavage of viral genomes and cessation of protein synthesis as well as through promoting death of infected cells, limiting the spread of virus. Importantly, OASs are pattern recognition receptors and the OAS–RNase L pathway is a primary innate response pathway to viruses, capable of early response, coming into play before IFN is induced or when the virus shuts down IFN signaling. |
topic |
murine coronavirus oligoadenylate-ribonuclease L interferon antagonist phosphodiesterase OAS3 ADAR1 |
url |
https://www.mdpi.com/2504-3900/50/1/14 |
work_keys_str_mv |
AT susanrweiss activationandantagonismoftheoasrnaselpathway |
_version_ |
1724741025898954752 |